VALN

Valneva SE
14.11
-0.05 (-0.35%)
Upgrade to Real-Time
Afterhours (Closed)
14.11
Volume 7,100
Bid Price 10.81
Ask Price 44.33
News -
Company Name Stock Ticker Symbol Market Type
Valneva SE VALN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.05 -0.35% 14.11 20:00:00
Open Price Low Price High Price Close Price Prev Close
14.18 14.0732 14.56 14.11 14.16
Trades Volume VWAP Dollar Volume Avg Volume
242 7,100  14.26  101,223 -
Last Trade Time Type Quantity Stock Price Currency
16:00:00 109  14.11 USD

Period:

Draw Mode:

Valneva SE Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 975.02M 69.10M 69.10M  395.91M  -156.98M -1.71 5.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News Valneva

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

VALN Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travellers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, and third-party products; Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; and Technologies and services which relates to services and inventions at a commercialization stage. The group is based in France and operates internationally.